hVIVO Company

hVIVO, a specialty biopharma company with clinical testing capabilities, is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases.
hVIVO changed its name from Retroscreen Virology in April 2015. The business is a plc quoted on the AIM London Stock Exchange (ticker ‘HVO’).
Technology: Drug Discovery
Industry: Personalized Medicine
Headquarters: London, England, United Kingdom
Founded Date: 1988
Employees Number: 501-1000
Funding Status: IPO

Visit Website
BD@hvivo.com
@hvivo_uk
Register and Claim Ownership